Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
Factor IX Therapy for Hemophilia B | IDELVION coagulation factor IX (recombinant), albumin fusion protein
IDELVION is the only extended half-life Factor IX therapy that delivers zero bleeds, 14-day dosing and 20% FIX trough levels for hemophilia B.
This website is hosted with AVENTIS BEHRING ZLB BEHRING, which reserves the following IP addresses for idelvion.com: 12.3.33.225. Moreover, DNS used with this website include dbru.br.ns.els-gms.att.net, dmtu.mt.ns.els-gms.att.net. Subnet identifier ranges from 12.3.33.0 to 12.3.33.255. Classless Inter-Domain Routing (CIDR) is 12.3.33.0/24. ARIN net type is Reassigned.
Daily Visitors
Last scanned
Domain Age
Global Rank
dbru.br.ns.els-gms.att.net
dmtu.mt.ns.els-gms.att.net
{{value}}
2014-09-04
2024-09-04
MarkMonitor Inc.
{{value}}
The registrar of idelvion.com is MarkMonitor Inc. and the name expires on 2024-09-04. According to open source data, you can reach the owner at csldomains@cslbehring.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
120.8K
2.1K